DK593083A - Praeparat og fremgangsmaade til undersoegelse af fordoejelsesfunktioner - Google Patents
Praeparat og fremgangsmaade til undersoegelse af fordoejelsesfunktioner Download PDFInfo
- Publication number
- DK593083A DK593083A DK593083A DK593083A DK593083A DK 593083 A DK593083 A DK 593083A DK 593083 A DK593083 A DK 593083A DK 593083 A DK593083 A DK 593083A DK 593083 A DK593083 A DK 593083A
- Authority
- DK
- Denmark
- Prior art keywords
- units
- tracer
- binding agent
- tracer binding
- gastric emptying
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000000700 radioactive tracer Substances 0.000 abstract 7
- 239000011230 binding agent Substances 0.000 abstract 5
- 230000030136 gastric emptying Effects 0.000 abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 230000002496 gastric effect Effects 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Farming Of Fish And Shellfish (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK183982 | 1982-04-23 | ||
| DK183982 | 1982-04-23 | ||
| DK8300047 | 1983-04-22 | ||
| PCT/DK1983/000047 WO1983003762A1 (en) | 1982-04-23 | 1983-04-22 | Composition and method for investigating alimentary functions |
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
| DK593083 | 1983-12-22 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK593083D0 DK593083D0 (da) | 1983-12-22 |
| DK593083A true DK593083A (da) | 1983-12-22 |
| DK157733B DK157733B (da) | 1990-02-12 |
| DK157733C DK157733C (da) | 1990-07-16 |
Family
ID=8108447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK593083A DK157733C (da) | 1982-04-23 | 1983-12-22 | Diagnostisk radioaktivt polydepotpraeparat, fremgangsmaade til fremstilling af dette og umaerket polydepotpraeparat, beregnet til at blive maerket med et radioaktivt sporstof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4657755A (da) |
| EP (1) | EP0092993B1 (da) |
| JP (1) | JPS59500614A (da) |
| AT (1) | ATE40949T1 (da) |
| CA (1) | CA1222947A (da) |
| DE (2) | DE3379256D1 (da) |
| DK (1) | DK157733C (da) |
| FI (1) | FI834776A7 (da) |
| NO (1) | NO834780L (da) |
| NZ (1) | NZ204009A (da) |
| WO (1) | WO1983003762A1 (da) |
| ZA (1) | ZA832904B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5165410A (en) * | 1987-05-15 | 1992-11-24 | Medical & Scientific Enterprises, Inc. | Position indicating system for a multidiagnostic scanner |
| US5261406A (en) * | 1991-01-15 | 1993-11-16 | Medasys Inc. | Whole body imaging system |
| US5407659A (en) * | 1991-10-22 | 1995-04-18 | Mallinckrodt Medical, Inc. | Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| US5342609A (en) * | 1991-10-22 | 1994-08-30 | Mallinckrodt Medical, Inc. | Microfluidization of calcium/oxyanion-containing particles |
| US5344640A (en) * | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
| US5350584A (en) * | 1992-06-26 | 1994-09-27 | Merck & Co., Inc. | Spheronization process using charged resins |
| US5520904A (en) * | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
| US5827497A (en) * | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| US20060073202A1 (en) * | 2004-10-05 | 2006-04-06 | Rocca Jose G | Dual component medicament delivery system |
| JP2009543886A (ja) * | 2006-07-19 | 2009-12-10 | スミスクライン・ビーチャム・コーポレイション | ガンマシンチグラフィー評価のために処方物を放射性標識する方法 |
| US10299745B2 (en) | 2014-12-29 | 2019-05-28 | Loyola University Of Chicago | Traceable devices for gastrointestinal use and methods of use and manufacturing the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2611730A (en) * | 1950-09-02 | 1952-09-23 | Simth Kline & French Lab | Medical preparation for reducing the body level of sodium |
| DK106457C (da) * | 1962-01-23 | 1967-02-06 | Ernst Helmer Hagstam | Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling. |
| NL7017227A (da) * | 1969-12-27 | 1971-06-29 | ||
| US4115540A (en) * | 1976-06-16 | 1978-09-19 | The University Of Kentucky Research Foundation | Radiodiagnostic agent |
| US4107283A (en) * | 1976-07-19 | 1978-08-15 | New England Nuclear Corporation | Tracer for circulation determinations |
| GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
| US4243652A (en) * | 1978-07-14 | 1981-01-06 | The Procter & Gamble Company | Gastrointestinal scanning agent |
| GB2057420B (en) * | 1979-08-30 | 1984-05-10 | Standard Telephones Cables Ltd | Controlled release glass |
-
1983
- 1983-04-22 DE DE8383302304T patent/DE3379256D1/de not_active Expired
- 1983-04-22 CA CA000426523A patent/CA1222947A/en not_active Expired
- 1983-04-22 DE DE198383302304T patent/DE92993T1/de active Pending
- 1983-04-22 EP EP83302304A patent/EP0092993B1/en not_active Expired
- 1983-04-22 JP JP58501422A patent/JPS59500614A/ja active Granted
- 1983-04-22 AT AT83302304T patent/ATE40949T1/de not_active IP Right Cessation
- 1983-04-22 US US06/568,184 patent/US4657755A/en not_active Expired - Fee Related
- 1983-04-22 WO PCT/DK1983/000047 patent/WO1983003762A1/en not_active Ceased
- 1983-04-25 ZA ZA832904A patent/ZA832904B/xx unknown
- 1983-04-26 NZ NZ204009A patent/NZ204009A/en unknown
- 1983-12-22 NO NO834780A patent/NO834780L/no unknown
- 1983-12-22 DK DK593083A patent/DK157733C/da not_active IP Right Cessation
- 1983-12-23 FI FI834776A patent/FI834776A7/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59500614A (ja) | 1984-04-12 |
| NO834780L (no) | 1983-12-22 |
| ZA832904B (en) | 1984-01-25 |
| DK593083D0 (da) | 1983-12-22 |
| WO1983003762A1 (en) | 1983-11-10 |
| EP0092993A3 (en) | 1984-07-18 |
| DE3379256D1 (en) | 1989-04-06 |
| ATE40949T1 (de) | 1989-03-15 |
| JPS6222971B2 (da) | 1987-05-20 |
| DK157733C (da) | 1990-07-16 |
| NZ204009A (en) | 1986-03-14 |
| EP0092993A2 (en) | 1983-11-02 |
| FI834776A0 (fi) | 1983-12-23 |
| DE92993T1 (de) | 1984-03-29 |
| FI834776A7 (fi) | 1983-12-23 |
| DK157733B (da) | 1990-02-12 |
| CA1222947A (en) | 1987-06-16 |
| US4657755A (en) | 1987-04-14 |
| EP0092993B1 (en) | 1989-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK593083A (da) | Praeparat og fremgangsmaade til undersoegelse af fordoejelsesfunktioner | |
| Figlin et al. | Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation. | |
| Wu et al. | Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo | |
| DE3479291D1 (en) | Enteric contrast agent for nuclear spin tomography, and its preparation | |
| NO811721L (no) | R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape | |
| DK0540613T3 (da) | Produkter og fremgangsmåder til behandling af fordøjelseskanalen | |
| Fedail et al. | Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases | |
| Kumar et al. | Significance of delayed 67Ga localization in the kidneys | |
| ARIEL | Radioactive isotopes for adjuvant cancer therapy: Animal experimentation and preliminary results in human application | |
| Gatley et al. | Studies with 17β (16α-[125I] iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors | |
| Reiman et al. | Quotient imaging with N‐13 L‐glutamate in osteogenic sarcoma: Correlation with tumor viability | |
| Fogelman et al. | The role of thyroid scanning in hyperthyroidism | |
| Vaira et al. | Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases | |
| Ogiński et al. | 99mTechnetium-Unithiol complex, a new pharmaceutical for kidney scintigraphy | |
| Bekdik et al. | An improved method for the in vivo labelling of red blood cells with 99mTc in gated cardiac imaging | |
| Krejs | Effect of vasoactive intestinal peptide in man | |
| EP0624365A1 (en) | A pharmaceutical form for the rectal administration of pharmacologically active compounds | |
| Song et al. | Metabolism of zinc-binding ligands in rat small intestine | |
| GB1561048A (en) | Radioactive labelled orgotein | |
| Prakash et al. | Localization of radioiodine in the tissues of swine: an autoradiographic study | |
| Hurwitz et al. | Distribution of 67Ga Following Intravenous Administration: Effects of Disodium Edetate Therapy | |
| Ercan et al. | Evidence for the histamine-mediated myotropic effect of angiotensin II in the rabbit aorta | |
| Martens et al. | In vitro studies on magnesium uptake by rumen epithelium using magnesium-28 | |
| Odeblad et al. | Uptake of radiosulphate in different organs after total body irradiation | |
| Abdel Wahab et al. | Kinetics and Distribution of Radioiodinated Thyroxine 131I in Wistar Albino Rats after Oral Ayministration of the Labelled Hormone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |